Actelion Ltd.Allschwil, Baselland Switzerland
Company Description
Drugmaker Actelion is anything but neutral in its fight against life-threatening diseases. The Swiss drugmaker develops and markets small molecule drugs in a number of therapeutic areas, including cardiovascular disease, oncology, and autoimmune disease. Actelion has several products on the market: It sells Tracleer worldwide and Ventavis in the US as treatments for pulmonary arterial hypertension (PAH), a serious disease characterized by high blood pressure in the arteries connecting the heart and lungs. The company also markets Zavesca, which treats an inherited metabolic disorder called Gaucher disease. Actelion has sales and marketing subsidiaries in more than 25 countries around the world.
| Gewerbestrasse 16 | Phone: +41-61-565-6565 | http://www.actelion.com |
| Allschwil, Baselland 4123 | Fax: +41-61-565-6500 | 
Map This Company |
| Switzerland |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Actelion Ltd. Rankings
| Swiss Market |
Executives
| 21 executives listed for Actelion Ltd.'s Allschwil, Baselland location. | ||
| Chairman | Robert Cawthorn | |
|---|---|---|
| Vice Chairman | André Mueller | |
| CEO and Director | Jean-Paul Clozel | |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Actelion Ltd. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
